Wikidata

(Q113914990)

English

A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

short name
AVONELLE-X (English)
0 references
title
A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Patients With Neovascular Age-Related Macular Degeneration (AVONELLE-X) (English)
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Brazil
0 references
Bulgaria
0 references
Canada
0 references
Denmark
0 references
France
0 references
Germany
0 references
Hong Kong
0 references
Hungary
0 references
Israel
0 references
Italy
0 references
Japan
0 references
Mexico
0 references
Netherlands
0 references
Poland
0 references
Portugal
0 references
Singapore
0 references
Spain
0 references
Switzerland
0 references
Taiwan
0 references
Turkey
0 references
United Kingdom
0 references
start time
19 April 2021
0 references
end time
9 August 2024
0 references
number of participants
1,036
0 references
minimum age
50 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q113914990&oldid=2149033982"